Dharmacon, Inc. (Acquired By Fisher Scientific International)

8 articles with Dharmacon, Inc. (Acquired By Fisher Scientific International)

• Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team as Chief Technology Officer

  9/25/2018

  Sirnaomics, Inc. announced today that Dmitry Samarsky, Ph.D., will be joining the company's senior management team as Chief Technology Officer.

• Lentigen Corporation And Dharmacon, Inc. Collaborate To Develop Custom Lentiviral Reagents For RNAi Research

  8/30/2006

• Abbott Laboratories And Dharmacon, Inc. Collaborate To Develop New siRNA-Based Therapeutics

  7/6/2006

• Dharmacon, Inc. RNAi Global Initiative Members Advance Standards For Genome-Wide RNAi Research In Second Meeting

  5/24/2006

• Fox Chase Cancer Center Joins Dharmacon, Inc. And International Research Institutes As Newest Member Of The Genome-Wide RNAi Global Initiative

  4/4/2006

• Dharmacon, Inc. Release: RNAi Global Initiative Members Meet To Establish Collaboration And Accelerate Biomedical Discovery Using Genome-Wide siRNA Library

  12/7/2005

• Dharmacon, Inc. And Alcon To Collaborate On Discovery Of New Therapies For Eye Diseases Using RNAi

  10/20/2005

• Dharmacon Launches siSTABLE(TM) siRNA With Greatly Increased Stability And Extended Silencing Longevity

  12/15/2003